Skip to content

Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety

Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842946
Enrollment
45
Registered
2009-02-12
Start date
2009-02-28
Completion date
2009-11-30
Last updated
2014-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Public Speaking, Social Fear

Brief summary

The purpose of this study is to compare two exposure-based behavioral group treatments for public speaking anxiety. Specifically, exposure within the context of psychological acceptance will be compared to exposure within a standard habituation context. It is hypothesized that participants receiving exposure within the context of psychological acceptance will experience a greater decrease in anxiety and greater improvement in quality of life compared to the habituation-based group.

Detailed description

Social Anxiety Disorder (SAD) is a potentially debilitating condition affecting approximately 12% of the population at some point in their life (Ruscio et al., 2008). Nongeneralized SAD refers to individuals whose fears are limited to one or two social situations, most commonly public speaking. Empirically supported treatments for public speaking anxiety generally include an exposure component involving participation in anxiety-provoking public speaking situations (usually simulated situations using an audience of confederates and/or fellow participants, as well as actual public speaking situations in the community). Exposure is often presented within the context of habituation, but cognitively- based therapies utilize a rationale for exposure based on cognitive restructuring and belief modification. Research investigating the incremental benefit of adding other treatment components to exposure has yielded mixed results; however, there is preliminary evidence that the context in which exposure is presented can have an impact on treatment outcome. Recently, acceptance-based therapies have begun to frame exposure as an opportunity to increase one's willingness to experience anxiety while engaging in valued behaviors, rather than as a vehicle for modifying maladaptive cognitions and reducing anxiety. However, little research has been conducted on the efficacy of acceptance-based therapies for public speaking anxiety, and no component control studies have examined the utility of an acceptance/cognitive defusion rationale and context for exposure for public speaking anxiety. The present study will compare two exposure-based treatments for public speaking anxiety in a clinical sample. Specifically, exposure within an acceptance/defusion context will be compared to exposure with a habituation-based rationale. Hypotheses: 1. Participants receiving exposure within an acceptance/defusion context will experience a greater reduction in anxiety and behavioral avoidance, and greater improvement in measures of quality of life, compared to participants receiving exposure within a habituation rationale, at post-treatment. 2. Acceptance, defusion, and mindfulness will mediate treatment outcome. Specifically, greater changes on measures of these three constructs will account for a significant portion of the effect of treatment condition on the dependent variables. 3. Lower baseline levels of public speaking anxiety and overall anxiety will be associated with higher baseline quality of life, mindfulness, acceptance, defusion, and social skills. 4. Baseline levels of acceptance, defusion, and mindfulness will predict overall treatment response, regardless of intervention condition.

Interventions

BEHAVIORALExposure w/ Acceptance-Based Rationale

Treatment focuses on the ineffectiveness of participants' past attempts to control or reduce their anxiety in public speaking situations. Acceptance of one's private experiences (thoughts, feelings, sensations) will be introduced. Willingness to experience unwanted thoughts and feelings while simultaneously engaging in valued activities, especially those related to public speaking, is stressed. Techniques designed to foster psychological acceptance are practiced prior to and during exposure exercises, as well as assigned for homework between sessions.

BEHAVIORALExposure w/ Habituation-Based Rationale

Exposure to feared public speaking situations are accompanied by explanations of behavioral principles, including classical/operant conditioning and habituation. The process of associating public speaking situations with unwanted feelings of anxiety will be discussed, as well as negative reinforcement of escape and avoidance behaviors. The underlying principle of habituation is reviewed. When engaging in exposure exercises (both in session and assigned homework exercises), participants will be encouraged to remain in the feared speaking situation until their subjective ratings of anxiety decrease.

Sponsors

Drexel University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinically diagnosable public speaking anxiety (per DSM-IV-TR criteria for nongeneralized social anxiety disorder) * Aged 18-65 * Residence in the greater Philadelphia area

Exclusion criteria

* Pervasive developmental disability * Acute suicide potential * Inability to travel to the treatment site * Certain comorbid Axis I diagnoses, namely: * generalized SAD * schizophrenia or other psychotic disorder * current substance dependence * Comorbid diagnoses of Major Depressive or other mood or anxiety disorders are acceptable ONLY if clearly secondary to the diagnosis of public speaking anxiety

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID))6-weeks post-treatmentThe SCID (First, Spitzer, Gibbon, & Williams, 1996) is an extensively utilized structured diagnostic interview based on DSM-IV criteria. Estimates of interrater reliability range from moderate to high for most Axis I disorders (e.g., Williams et al., 1992; Zanarini & Frankenburg, 2001).

Countries

United States

Participant flow

Participants by arm

ArmCount
Acceptance
Behavioral exposure within the context of psychological acceptance.
21
Habituation
Behavioral exposure within the context of habituation.
24
Total45

Baseline characteristics

CharacteristicHabituationAcceptanceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants21 Participants45 Participants
Age, Continuous29.96 years
STANDARD_DEVIATION 8.41
34.20 years
STANDARD_DEVIATION 12.4
31.93 years
STANDARD_DEVIATION 10.55
Region of Enrollment
United States
24 participants21 participants45 participants
Sex: Female, Male
Female
18 Participants18 Participants36 Participants
Sex: Female, Male
Male
6 Participants3 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 24
serious
Total, serious adverse events
0 / 210 / 24

Outcome results

Primary

Number of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID))

The SCID (First, Spitzer, Gibbon, & Williams, 1996) is an extensively utilized structured diagnostic interview based on DSM-IV criteria. Estimates of interrater reliability range from moderate to high for most Axis I disorders (e.g., Williams et al., 1992; Zanarini & Frankenburg, 2001).

Time frame: 6-weeks post-treatment

ArmMeasureValue (NUMBER)
AcceptanceNumber of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID))21 participants
HabituationNumber of Participants in Remission (Per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID))20 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026